A vaccine against HIV has been able to activate the immune system

This Saturday published a survey that describes that an HIV vaccine is getting promising results, although according to Dan Barouch, the head of the study, clarifies in a note that he is necessary to interpret them with caution.

AIDS was not discovered until the early 1980s when American doctors observed that there was a group of patients with rare diseases and since that time has caused the Death of more than 35 million people according to WHO figures . It's slightly different from HIV. The Human Immunodeficiency Virus (HIV) infects cells of the immune system, altering or canceling their function, resulting in a gradual deterioration of the immune system; Acquired Immunodeficiency Syndrome (AIDS), on the other hand, is a term applied to the most advanced stages of infection with this virus.

In scientific work published in the prestigious medical journal The Lancet, an HIV vaccine experienced with about 393 people, was safe and able to activate the immune system. According to the article the experimental vaccine against HIV-1 is tolerated by adult humans and rhesus macaques.

The volunteers of this research came from Thailand, the United States and South Africa. The tests carried out also showed that this could work in humans from different parts of the planet and that previous attempts were limited to certain geographical areas it was difficult to generalize the results. In macaques, he showed a very high protection.

The authors of the book seek caution with their findings: "The challenges in the development of an HIV vaccine are unprecedented and the ability to induce a specific immune response to HIV that n & # 39; It does not necessarily indicate that the vaccine will protect humans against HIV infection, "added Barouch, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center (Boston, USA) and lead author of the trial.

] On the basis of this research, a long-term clinical trial will be conducted and will vaccinate 2,600 women in South Africa at risk of acquiring HIV. This is the next phase of this work that keeps some reserve.